Cargando…
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI
We evaluated differences in density and (18)F-FDG PET/MRI features of lytic bone lesions (LBLs) identified by whole-body low-dose CT (WB-LDCT) in patients affected by newly diagnosed multiple myeloma (MM). In 18 MM patients, 135 unequivocal LBLs identified by WB-LDCT were characterized for inner den...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373185/ https://www.ncbi.nlm.nih.gov/pubmed/30539276 http://dx.doi.org/10.1007/s00277-018-3555-7 |
_version_ | 1783394926047789056 |
---|---|
author | Zambello, Renato Crimì, Filippo Lico, Albana Barilà, Gregorio Branca, Antonio Guolo, Annamaria Varin, Cristiano Vezzaro, Roberto Checuz, Lucia Scapin, Vanna Berno, Tamara Pizzi, Marco Ponzoni, Alberto De Biasi, Ercole Vio, Stefania Semenzato, Gianpietro Zucchetta, Pietro Lacognata, Carmelo |
author_facet | Zambello, Renato Crimì, Filippo Lico, Albana Barilà, Gregorio Branca, Antonio Guolo, Annamaria Varin, Cristiano Vezzaro, Roberto Checuz, Lucia Scapin, Vanna Berno, Tamara Pizzi, Marco Ponzoni, Alberto De Biasi, Ercole Vio, Stefania Semenzato, Gianpietro Zucchetta, Pietro Lacognata, Carmelo |
author_sort | Zambello, Renato |
collection | PubMed |
description | We evaluated differences in density and (18)F-FDG PET/MRI features of lytic bone lesions (LBLs) identified by whole-body low-dose CT (WB-LDCT) in patients affected by newly diagnosed multiple myeloma (MM). In 18 MM patients, 135 unequivocal LBLs identified by WB-LDCT were characterized for inner density (negative or positive Hounsfield unit (HU)), where negative density (HU < 0) characterizes normal yellow marrow whereas positive HU correlates with tissue-like infiltrative pattern. The same LBLs were analyzed by (18)F-FDG PET/DWI-MRI, registering DWI signal with ADC and SUV max values. According to HU, 35 lesions had a negative density (− 56.94 ± 31.87 HU) while 100 lesions presented positive density (44.87 ± 23.89 HU). In seven patients, only positive HU LBLs were demonstrated whereas in eight patients, both positive and negative HU LBLs were detected. Intriguingly, in three patients (16%), only negative HU LBLs were shown. At (18)F-FDG PET/DWI-MRI analysis, negative HU LBLs presented low ADC values (360.69 ± 154.38 × 10(−6) mm(2)/s) and low SUV max values (1.69 ± 0.56), consistent with fatty marrow, whereas positive HU LBLs showed an infiltrative pattern, characterized by higher ADC (mean 868.46 ± 207.67 × 10(−6) mm(2)/s) and SUV max (mean 5.04 ± 1.94) values. Surprisingly, histology of negative HU LBLs documented infiltration by neoplastic plasma cells scattered among adipocytes. In conclusion, two different patterns of LBLs were detected by WB-LDCT in MM patients. Both types of lesions were indicative for active disease, although only positive HU LBL were captured by (18)F-FDG PET/DWI-MRI imaging, indicating that WB-LDCT adds specific information. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00277-018-3555-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6373185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63731852019-03-01 Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI Zambello, Renato Crimì, Filippo Lico, Albana Barilà, Gregorio Branca, Antonio Guolo, Annamaria Varin, Cristiano Vezzaro, Roberto Checuz, Lucia Scapin, Vanna Berno, Tamara Pizzi, Marco Ponzoni, Alberto De Biasi, Ercole Vio, Stefania Semenzato, Gianpietro Zucchetta, Pietro Lacognata, Carmelo Ann Hematol Original Article We evaluated differences in density and (18)F-FDG PET/MRI features of lytic bone lesions (LBLs) identified by whole-body low-dose CT (WB-LDCT) in patients affected by newly diagnosed multiple myeloma (MM). In 18 MM patients, 135 unequivocal LBLs identified by WB-LDCT were characterized for inner density (negative or positive Hounsfield unit (HU)), where negative density (HU < 0) characterizes normal yellow marrow whereas positive HU correlates with tissue-like infiltrative pattern. The same LBLs were analyzed by (18)F-FDG PET/DWI-MRI, registering DWI signal with ADC and SUV max values. According to HU, 35 lesions had a negative density (− 56.94 ± 31.87 HU) while 100 lesions presented positive density (44.87 ± 23.89 HU). In seven patients, only positive HU LBLs were demonstrated whereas in eight patients, both positive and negative HU LBLs were detected. Intriguingly, in three patients (16%), only negative HU LBLs were shown. At (18)F-FDG PET/DWI-MRI analysis, negative HU LBLs presented low ADC values (360.69 ± 154.38 × 10(−6) mm(2)/s) and low SUV max values (1.69 ± 0.56), consistent with fatty marrow, whereas positive HU LBLs showed an infiltrative pattern, characterized by higher ADC (mean 868.46 ± 207.67 × 10(−6) mm(2)/s) and SUV max (mean 5.04 ± 1.94) values. Surprisingly, histology of negative HU LBLs documented infiltration by neoplastic plasma cells scattered among adipocytes. In conclusion, two different patterns of LBLs were detected by WB-LDCT in MM patients. Both types of lesions were indicative for active disease, although only positive HU LBL were captured by (18)F-FDG PET/DWI-MRI imaging, indicating that WB-LDCT adds specific information. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00277-018-3555-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-12-11 2019 /pmc/articles/PMC6373185/ /pubmed/30539276 http://dx.doi.org/10.1007/s00277-018-3555-7 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Zambello, Renato Crimì, Filippo Lico, Albana Barilà, Gregorio Branca, Antonio Guolo, Annamaria Varin, Cristiano Vezzaro, Roberto Checuz, Lucia Scapin, Vanna Berno, Tamara Pizzi, Marco Ponzoni, Alberto De Biasi, Ercole Vio, Stefania Semenzato, Gianpietro Zucchetta, Pietro Lacognata, Carmelo Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title | Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title_full | Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title_fullStr | Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title_full_unstemmed | Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title_short | Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI |
title_sort | whole-body low-dose ct recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at pet/mri |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373185/ https://www.ncbi.nlm.nih.gov/pubmed/30539276 http://dx.doi.org/10.1007/s00277-018-3555-7 |
work_keys_str_mv | AT zambellorenato wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT crimifilippo wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT licoalbana wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT barilagregorio wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT brancaantonio wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT guoloannamaria wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT varincristiano wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT vezzaroroberto wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT checuzlucia wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT scapinvanna wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT bernotamara wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT pizzimarco wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT ponzonialberto wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT debiasiercole wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT viostefania wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT semenzatogianpietro wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT zucchettapietro wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri AT lacognatacarmelo wholebodylowdosectrecognizestwodistinctpatternsoflyticlesionsinmultiplemyelomapatientswithdifferentdiseasemetabolismatpetmri |